Free Trial
OTCMKTS:BIEI

Premier Biomedical (BIEI) Stock Price, News & Analysis

Premier Biomedical logo
$0.0008 0.00 (-11.11%)
As of 12:28 PM Eastern

About Premier Biomedical Stock (OTCMKTS:BIEI)

Advanced

Key Stats

Today's Range
$0.0007
$0.0009
50-Day Range
N/A
52-Week Range
$0.0003
$0.0017
Volume
578,221 shs
Average Volume
6.57 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Premier Biomedical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
6th Percentile Overall Score

BIEI MarketRank™: 

Premier Biomedical scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Premier Biomedical.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Premier Biomedical is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Premier Biomedical is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Premier Biomedical has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Premier Biomedical has recently increased by 163.04%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Premier Biomedical does not currently pay a dividend.

  • Dividend Growth

    Premier Biomedical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Premier Biomedical has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Premier Biomedical has recently increased by 163.04%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Premier Biomedical has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.63 average news sentiment score of Medical companies.
  • Search Interest

    1 people have searched for BIEI on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added Premier Biomedical to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Premier Biomedical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    36.78% of the stock of Premier Biomedical is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Premier Biomedical's insider trading history.
Receive BIEI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Premier Biomedical and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BIEI Stock News Headlines

Premier Graphene Showcases Hemp Graphene for Military Use
Forget NVDA. Put $1,000 into this stock now
A massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW kind of AI stock.tc pixel
See More Headlines

BIEI Stock Analysis - Frequently Asked Questions

Premier Biomedical's stock was trading at $0.0007 at the start of the year. Since then, BIEI stock has increased by 14.3% and is now trading at $0.0008.

Shares of BIEI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Premier Biomedical investors own include Allena Pharmaceuticals (ALNA), Inovio Pharmaceuticals (INO), Co-Diagnostics (CODX), CytoDyn (CYDY), Vaxart (VXRT), Arcturus Therapeutics (ARCT) and Actinium Pharmaceuticals (ATNM).

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:BIEI
CIK
1515740
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (OTCMKTS:BIEI) was last updated on 9/18/2025 by MarketBeat.com Staff
From Our Partners